• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in...

cafead

Administrator
Staff member
  • cafead   Oct 18, 2023 at 11:42: AM
via Four weeks ago, Seagen and Astellas made waves when they revealed that the pairing of Padcev with Merck’s oncology superstar Keytruda had achieved improved outcomes over standard of care in patients with previously untreated bladder cancer.

article source
 

<